Search Results 6771-6780 of 42555 for oral

  1. Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis - Mayo Clinic

    Nasal or oral inflammation: painful or painless oral ulcers or purulent or blood nasal discharge; Abnormal chest radiograph: nodules, fixed infiltrates, or ...

  2. Recurrent breast cancer - Diagnosis and treatment - Mayo Clinic

    Learn about symptoms that alert doctors to a breast cancer recurrence and strategies for treating cancer that comes back after initial treatment.

  3. Selective IgA deficiency - Symptoms and causes - Mayo Clinic

    A lack of the disease-fighting antibody called immunoglobulin A (IgA) may cause frequent infections or serious complications.

  4. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology ... r, Oral and throat cancer, Mouth cancer, Thyroid cancer, Head and neck ...

  5. A Study to Evaluate Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat Atrial Fibrillation (AF) - Mayo Clinic

    Patient who is not on oral anticoagulation therapy for at least 3 weeks prior to the ablation procedure. Presence of a permanent pacemaker, biventricular ...

  6. Myocardial Mechanisms in HFpEF - Clinical Trials

    Therapy with direct oral anticoagulants without cessation for a period (age, renal function, and agent specific) deemed adequate to normalize coagulation ...

  7. A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma - Mayo Clinic

    Patients will be randomized to receive oral daily doses of vismodegib 150 mg or m atching placebo. The anticipated time on study drug treatment is 12 weeks ...

  8. Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment (enrollment by invitation only) - Mayo Clinic

    Currently hospitalized with fever defined as temperature ≥ 36.6 °C armpit, ≥ 37.2 °C oral, or ≥ 37.8 °C rectal; Peripheral capillary oxygen saturation ...

  9. Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes - Mayo Clinic

    All diabetic subjects should be on stable dose oral agent therapy for 3 months prior to enrollment. Exclusion Criteria: Subjects with cerebrovascular or ...

  10. A Study to Evaluate Optimal Target of Activated Clotting Time During Percutaneous Coronary Intervention and Outcomes - Mayo Clinic

    Use of warfarin (vitamin K antagonist) or direct oral anticoagulant. Patients on LMWH bridging strategy. PCI within prior 30 days. Planned use of ...